Ryan is an Associate at Cooley LLP & practices general corporate and securities law, with emphasis on the representation of emerging growth companies, venture capital funds and public companies.
While attending Duke University School of Law, he was awarded the Faculty Award for Business Organization and Finance Law. He served as articles editor of the Alaska Law Review and took part in the Duke Law Entrepreneurship Clinic. Additionally, Ryan studied law at the Université de Genève in Switzerland and the Universität Heidelberg in Germany. Ryan is a member of the State Bar of California.
About Cooley LLC
40+ years representing leading global life sciences companies
40% of the companies on the Wall Street Journal’s Billion Dollar Start-up Club list use Cooley
300+ life sciences corporate partnering and licensing deals since 2010
1,300+ M&A transactions for an aggregate value of $440+ billion since 2012
#1 law firm for tech and life sciences IPOs
280+ funds formed with $27+ billion raised in 2018
Consistently rank #1 for global biotech & pharma licensing — BioPharm Insight
#1 in issuer-side life sciences IPOs since 2000
#1 for biotech and pharma venture financings for the last decade, including in 2018 — PitchBook
#2 M&A law firm for biotech and pharma M&A transactions in 2018, 2019 & Q3 2020
"Highly Recommended” law firm for general corporate, licensing & collaborations, and M&A in 2019 — LMG Life Sciences
Dedicated, international practice group of 40+ professionals across the US, Europe and China exclusively focused on corporate partnering, licensing, M&A and other commercial transactions specific to life sciences companies